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nary artery bypass grafting have a decrease in ejection
fraction or cardiac index in the immediate postoperative
period as compared with respective preoperative val-
ues.1 Although there have been changes in cardioplegic
solution composition and changes in the methods of
delivering the solution over the past 20 years, this is still
a significant cause of morbidity and mortality in the
postoperative period.
Adenosine was introduced as an additive to cardio-
plegic solution in 1980 by Foker, Einziz, and Wang.2
Since that time numerous studies have detailed the
improved myocardial protection attributable to adeno-
sine supplementation of cardioplegic solution.3-5
However, the fundamental mechanism or mechanisms
by which adenosine augments myocardial protection
during cardioplegic arrest are incompletely understood.
Silverman and associates6 theorized that adenosine pro-
vides ultrastructural substrate for adenosine triphos-
M yocardial depression after cardiac surgical proce-dures is a common clinical occurrence. Studies
have shown that up to 90% of patients undergoing coro-
Objective: Adenosine supplementation of cardioplegic solutions in car-
diac operations improves postarrest myocardial recovery after cardio-
plegic arrest and reperfusion; however, the mechanism of the action of
adenosine remains unknown. We tested the hypotheses that adenosine-
supplemented cardioplegic solution improves myofibrillar protein coop-
erative interaction and increases myocardial anaerobic glycolysis.
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tions: (1) St Thomas’ Hospital No. 2 cardioplegic solution (St Thomas
group), (2) St Thomas’ Hospital No. 2 cardioplegic solution plus adeno-
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two groups, independent of coronary flow. Adenosine supplementation
of cardioplegic solution prevented the decrease in myofibrillar protein
cooperative interaction seen after cardioplegic arrest and reperfusion
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MECHANISMS OF MYOCARDIAL PROTECTION BY ADENOSINE-SUPPLEMENTED CARDIOPLEGIC
SOLUTION: MYOFILAMENT AND METABOLIC RESPONSES
phate (ATP) repletion and thus attenuates the depres-
sion of high-energy phosphates after cardioplegic arrest
and reperfusion. However, in 1994 Hudspeth and
coworkers3 reported that the actions of adenosine in
cardioplegia are receptor mediated. Much work has
been done to further our understanding of the mecha-
nisms of the receptor-mediated actions of adenosine in
normothermic perfused and ischemic hearts,7-13 but it
would be presumptive to extrapolate these findings to
the cardioplegia setting. Indeed, the response of
myofilaments to cardioplegic arrest differs significant-
ly from the response seen in warm ischemic injury.14
The hypothermia alone, typical of cardioplegic arrest,
can alter enzyme kinetics and receptor binding charac-
teristics.
Earlier studies in our laboratory demonstrated that
cardioplegic arrest induces changes that are reflected in
altered biochemical interactions in the myofibrillar
contractile apparatus.14 Specifically, the cooperative
interaction of the actin-myosin Mg+2 ATPase enzyme
activity is decreased, which would contribute to
depressed systolic and diastolic functional recovery.
We therefore tested the hypothesis that adenosine, via a
receptor-mediated process, attenuates or prevents the
decrease in the myofibrillar protein cooperative inter-
action seen after cardioplegic arrest and reperfusion.
Another potential mechanism by which adenosine
might protect the arrested heart is via potentiation of
cardiac glycolysis. Glycolysis is vital to protecting car-
diac function during warm ischemia,8 conditions of
reduced oxygen supply in relation to demand,10 and
during cardioplegic arrest.15 Adenosine can potentiate
cardiac glycolysis,11-13 and this response is important
under normothermic conditions.8,10 Again, however,
these results cannot be extrapolated easily to the setting
of cold cardioplegic arrest, a setting of significantly
reduced biochemical processes and energy require-
ments. Therefore we thought it important to determine
whether adenosine-mediated potentiation of glycolysis
played a role in the ability of adenosine to protect the
heart during cardioplegic arrest. To this end, we tested
the hypothesis that increased myocardial glycolysis is
associated with the salutary effects of adenosine in car-
dioplegia.
Methods
The animals used in the experiments reported herein
received humane care in compliance with the “Guide for the
Care and Use of Laboratory Animals,” prepared by the
Institute of Laboratory Animal Resources and published by
the National Institutes of Health (NIH publication 86-23,
revised 1985).
Isolated heart protocol. Male Sprague-Dawley rats (373.1
± 8.5 gm) were randomized to 1 of 4 experimental groups
(see “Experimental groups” section). Rats were anesthetized
with a 50 mg/kg dose of intraperitoneal pentobarbital sodium.
After adequate anesthesia was ensured by absence of the
deep pain reflex to interdigital pinch, a laparotomy was per-
formed. Two minutes after injection of 200 units of heparin
into the inferior vena cava the chest was rapidly opened and
the heart was removed and placed in ice-cold Krebs Ringer
bicarbonate buffer. Extraneous tissue was dissected free, the
left and right ventricles vented with a 20-gauge needle, and
the aortic root rapidly cannulated. The cannula was then con-
nected to a non-recirculating, temperature-controlled, isolat-
ed heart perfusion apparatus. The heart was perfused in an
aortic retrograde (coronary antegrade) fashion at a constant
pressure of 80 mm Hg with warm (37°C) oxygenated (95.5%
oxygen/4.5% carbon dioxide) modified Krebs Ringer bicar-
bonate buffer containing 100 mmol/L NaCl, 4.74 mmol/L
KCl, 1.12 mmol/L CaCl2, 1.18 mmol/L MgSO4, 25 mmol/L
NaHCO3, and 1.18 mmol/L KH2PO4 and modified with the
addition of 11.4 mmol/L glucose, 4.92 mmol/L pyruvate, and
5.38 mmol/L fumarate. After gas equilibration, the pH was
titrated to 7.4 with 0.1N HCl and KOH. Hearts were paced at
300 beats/min with bipolar silver electrodes embedded in the
right atrium at 125% of the minimal voltage required to pace
the heart at a duration of 6 ms with a Grass SD9 stimulator
(Grass Instruments, Quincy, Mass). A latex balloon sur-
rounding a microtransducer-tipped Millar catheter with
lumen (Millar Instruments, Houston, Tex) was inserted into
the left ventricle via the mitral valve. The Millar catheter was
connected to an AT class computer (Dell, Inc, Austin, Tex)
and data were recorded using the CODAS data acquisition
system (DATAQ, Inc, Akron, Ohio) at a digital conversion
frequency of 250 samples per second per channel. The latex
balloon was inflated and deflated multiple times to adequate-
ly seat the balloon in the left ventricle. Sufficient volume was
then kept in the balloon to maintain a stable left ventricular
end-diastolic pressure (LVEDP) of 0 to 2 mm Hg. The prepa-
ration was considered stable if the diastolic and systolic pres-
sures remained constant (diastolic pressure variation < 2 mm
Hg; systolic variation < 5 mm Hg) for 15 minutes. Hearts
were excluded if the developed pressure was less than 60 mm
Hg or if they exhibited ventricular arrhythmias or were
unable to be paced.
Experimental protocol. After a 15-minute stabilization
period, measurements of left ventricular pressure (LVP) were
recorded and variably loaded pressure-volume (Starling)
curves generated via incremental (5 µL) volume unloading
by means of a Harvard pump (model 55-2226; Harvard
Apparatus Co, South Natick, Mass). Volume was slowly
added into the left ventricular balloon until an end-diastolic
pressure of 20 mm Hg was reached. The volume was then
removed from the balloon in 5-µL decrements until an end-
diastolic pressure of 0 mm Hg or less was reached. After the
withdrawal of each successive 5-µL volume, the ventricle
was allowed to stabilize for 15 seconds and LVP tracings
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were recorded. This procedure was then repeated starting
again at an end-diastolic pressure of 20 mm Hg. In addition
to these readings, coronary flow was measured and effluent
samples for glucose and lactate measurement were obtained
and later analyzed (YSI model 2300; Yellow Springs, Ohio).
Then 3 mL of one of the three cardioplegic solutions (see
“Experimental groups” section) at 4°C was infused into the
aortic cannula to arrest the heart. Infusion pressure was mon-
itored to prevent the infusion pressure from rising above 60
mm Hg. Thereafter 1 mL of cardioplegic solution was infused
every 15 minutes for a total arrest time of 120 minutes.
Glucose and lactate effluent samples were obtained during
infusion of the cardioplegic solution at 30, 60, and 90 minutes
of cardioplegic arrest. At the end of the 120-minute cardio-
plegic arrest period, hearts were reperfused with warm oxy-
genated Krebs Ringer bicarbonate buffer (as used during the
stabilization period) for 1 hour. At 30 and 60 minutes of
reperfusion, hemodynamic measurements were obtained in
the same manner as described previously, and coronary flow
measurements and effluent samples for glucose and lactate
levels were collected. At the end of 60 minutes of reperfu-
sion, hearts were freeze-clamped with Dry Ice and stored at
–70°C for later biochemical analysis.
Experimental groups. All cardioplegic solutions were
oxygenated with 95.5% oxygen/4.5% carbon dioxide and
maintained at a temperature of 4°C. The first group (ST#2)
received St Thomas’ Hospital No. 2 cardioplegic solution.
This solution comprised 110 mmol/L NaCL, 16 mmol/L KCl,
1.2 mmol/L CaCl2, 16 mmol/L MgCl2, and 10 mmol/L
Na2HCO3. To determine the effects of exogenous adenosine
supplementation on myocardial protection, the second group
(ADO) received a cardioplegic solution that consisted of St
Thomas’ Hospital No. 2 solution supplemented with adeno-
sine (Sigma, St Louis, Mo) to a final concentration of 100
µmol/L. The third group (SPT) received a cardioplegic solu-
tion that consisted of St Thomas’ Hospital No. 2 solution plus
adenosine (100 µmol/L) plus the nonspecific adenosine
receptor blocker 8-p-sulfophenyltheophylline (50 µmol/L;
Research Biochemicals International, Natick, Mass). The
purpose of the third group was to determine which effects of
adenosine during cardioplegic arrest were adenosine-receptor
mediated. The doses of adenosine and 8-p-sulfophenyltheo-
phylline were based on doses used in other studies.9 A sepa-
rate fourth group of hearts (No CPL) did not undergo cardio-
plegic arrest. Instead, these hearts were perfused with warm,
oxygenated Krebs Ringer bicarbonate buffer for 60 minutes
after baseline readings were obtained (total perfusion time,
90 minutes). These hearts were used for comparison of func-
tional and biochemical changes associated with the total
amount of time all hearts underwent beating, warm, oxy-
genated perfusion. Animals were randomly assigned to one of
the experimental groups until a minimum of 6 rats in each
group was attained. The requirement of a minimum of 6 rats
per group was based on the variance of myofibrillar ATPase
data being measured, applied to power analysis with α set at
.8 and P < .05 required for statistical significance. Random
assignment of rats to these groups resulted in 7 rats in the
ST#2 group, 6 rats in the ADO group, 8 rats in the SPT group,
and 6 rats in the No CPL group (total 27 rats).
Functional analysis
Systolic function. To assess systolic function across time
and between the groups, systolic pressure was obtained at 2
and 10 mm Hg preload pressure. The maximal value of the
first derivative of pressure over time (peak [+]dP/dt) was
determined at an LVEDP of 10 mm Hg.
Diastolic function: compliance measurements. Diastolic
compliance was determined from data defining the end-dia-
stolic pressure-volume relationship (EDPVR). The LVEDP
for each cardiac cycle was defined as the point on the LVP
tracing that corresponded to the first (+)dP/dt value greater
than 50 mm Hg/s. This value of LVEDP corresponded to the
point on the LVP tracing immediately preceding the rapid
upstroke of systole. LVEDP values were averaged for 4 car-
diac cycles at each preload volume. The values for the
EDPVR were fit to the following equation: LVP = A + B ·
(expC · Vx–1), where A is the Y intercept and B and C are mod-
ifiers of the exponential curvature of the EDPVR.16 Volume
strain was calculated by normalizing volume for the equilib-
rium volume (V
o
), which is the volume at LVP = 0. Volume
strain was calculated by the equation V
n
= (V – V
o
)/V
o
. To
determine compliance, volume strain was plotted against
stress (pressure millimeters of mercury). This relationship
was fitted to the equation Y = A · (expB · Vn–1), where A and
B are modifiers of the exponential curvature of the stress/
strain relationship. Changes in regression coefficients from
baseline values were analyzed for significant alterations in
compliance after cardioplegic arrest.
Myofibrillar preparations. Left ventricular myofibrillar
proteins were isolated by use of a modification of the gener-
al method of Pagani and Solaro, as previously reported.14 All
isolation procedures were done at 0°C to 4°C and all solu-
tions contained leupeptin (0.5 mg/mL), pepstatin A (0.5
mg/mL), and phenylmethylsulfonyl fluoride (0.2 mmol/L) to
inhibit proteolytic enzymes. Ventricles were minced in a
solution containing 10 mmol/L EGTA,* 2 mmol/L MgATP, 6
mmol/L phosphocreatine, 1.65 mmol/L Mg2+, 36 mmol/L
KCl, and 60 mmol/L imidazole, homogenized, and cen-
trifuged. The pellet was resuspended in the solution described
(except EGTA was reduced to 0.1 mmol/L) and centrifuged.
To remove membrane contaminates, the pellet was resus-
pended in standard buffer (60 mmol/L KCl, 2.0 mmol/L
MgCl2, 30 mmol/L imidazole; pH 7.0) containing 1% Triton
X-100 (vol/vol), left on ice for 20 minutes, and centrifuged.
The pellet was washed by repeating the resuspension in stan-
dard buffer and the centrifugation steps 3 times. Myofilament
protein concentration was determined by means of the modi-
fied Lowry protein assay described by Pagani and Solaro, as
previously reported.14
ATPase measurements. Ca2+-dependent myofibrillar
ATPase activities were measured as described previously.14
In brief, myofibrillar Ca2+-dependent MgATPase activity was
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*Ethyleneglycoltetraacetic acid.
measured in a reaction solution containing 0.2 to 0.5 mg/mL
myofibrillar protein, 66 mmol/L KCl, 2 mmol/L Mg2+, 60
mmol/L imidazole (pH 7.0), 1 mmol/L EGTA, and 5 mmol/L
MgATP2– and varied Ca2+ concentrations (pCa 8.0 to 4.5; pCa
= –log [Ca2+]). The ATPase reaction was initiated with the
addition of ATP and stopped after 10 minutes with 10% cold
trichloroacetic acid. The reaction mixture was centrifuged at
4°C to pellet the protein. Inorganic phosphate produced by
ATP hydrolysis was measured in the supernatant fraction by
the method of Carter and Karl, as previously reported.14
ATPase activities were reported as nanomoles inorganic
phosphate produced per milligram protein per minute.
Statistics. All values are presented as means ± SEM. After
homogeneity of variance was assured, group and/or time dif-
ferences were determined by 1-way and 2-way analyses of
variance as appropriate (see following paragraph). The num-
ber of samples per group was as indicated previously, with
exceptions indicated in the text and legends where measure-
ments were unattainable because of technical difficulties.
Hemodynamic data and glycolytic variable measurements
were analyzed by 2-way analysis of variance, with group
and time as the 2 factors. Where the F value indicated sig-
nificance, differences were isolated by the Student-
Newman-Keuls post hoc test. Compliance curves were fit
with use of a Levenberg-Marquardt algorithm. Comparisons
of compliance curve coefficients (after natural logarithmic
transformation) and equilibrium volumes at 30 and 60 min-
utes of reperfusion to baseline values were made after 2-
way analysis of variance, followed by the least significant
difference test (using the analysis of variance error mean
square term), comparing to a population mean equal to zero
change.
For myofibrillar ATPase activity, data from the pCa-
ATPase activity relation were fit to the equation Y = A + [(B
- A)/(1 + (10C/10X)D)] using nonlinear regression analysis to
derive minimal (A) and maximal (B) ATPase activities, the
[Ca2+] at half maximal ATPase activity (C), and the Hill
coefficient (D), which characterizes the cooperativity of the
relation. In this equation, Y was equal to inorganic phosphate
liberated by ATPase activity and X was the [Ca+2]. The pCa50
(the pCa at which half-maximal activity occurs) was deter-
mined by taking the –log[coefficient C]. A 1-way analysis of
variance was used to test for differences between groups in
minimal and maximal ATPase activities, pCa50, and the Hill
coefficient after log transformation, when required.
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Fig 1. Left ventricular systolic pressures at preload pressures
of 2 and 10 mm Hg. At 2 mm Hg systolic pressure preload
(top panel), the systolic pressure generated in the ST#2 group
(n = 7) decreased significantly from baseline at 30 and 60
minutes of reperfusion. In the adenosine-supplemented group
(ADO; n = 6) there was no significant decrease in systolic
pressure generated. However, in the adenosine-receptor–
blocked group (SPT; n = 7) there was a significant decrease
in systolic pressure generation at both 30 and 60 minutes of
reperfusion. Similar results were obtained at 10 mm Hg pre-
load pressure (bottom panel). *P < .05 compared with baseline.
Fig 2. Compliance (stress/strain) curves for a representative
heart in the ST#2 group. Data points (open circles) were fit to
the monoexponential equation: Stress = A · (expB · Vn–1).
Before cardioplegic arrest the values of regression coeffi-
cients A and B were 22.817 and 1.869, respectively. After 60
minutes of reperfusion, coefficients A and B increased to
27.914 and 2.237, respectively. These changes in A and B
translate to a decrease in compliance or a shift of the compli-
ance curves up and to the left. V
o
, Equilibrium volume.
Results
Cardiac function. Systolic pressure is represented at
2 and 10 mm Hg preload pressures (Fig 1). For the
ST#2 group, left ventricular systolic pressure was sig-
nificantly decreased at 30 and 60 minutes of reperfusion
after cardioplegic arrest, at both levels of preload. In the
ADO group, in which the cardioplegic solution was
supplemented with 100 µmol/L adenosine, there was no
significant change in systolic pressure from baseline
values (P = .4), indicating attenuation of myocardial
depression. These values were not significantly differ-
ent from those observed in the group of hearts that did
not undergo cardioplegic arrest (No CPL; data not
shown). When the adenosine receptor blocker 8-p-sul-
fophenyltheophylline was added to the cardioplegic
solution (SPT group), the maintenance of systolic func-
tion seen in the adenosine group was ablated, indicating
that the salutary effects of adenosine were receptor
mediated. When the systolic function in the SPT group
was compared with that in the ST#2 group, there were
no significant differences (P = .4), but the systolic
recovery was consistently lower in the SPT group than
in the ST#2 group at all times and preload pressures.
This suggested that the 8-p-sulfophenyltheophylline
blocked not only the effects of the exogenous adenosine
in the adenosine group, but also endogenous adenosine
produced in the ST#2 group.
Peak (+)dP/dt and coronary flow rates are shown in
Table I. All three groups that had undergone cardio-
plegic arrest demonstrated significant depression of
maximum (+)dP/dt by 60 minutes of reperfusion. In the
SPT group, peak (+)dP/dt was significantly lower at 60
minutes of reperfusion than in the ADO group at the
same time, demonstrating blockade of the functional
recovery seen in the ADO group. At 60 minutes of
reperfusion the value of peak (+)dP/dt was also higher
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Table I. Peak (+)dP/dt and coronary flow rates
Group
Time ST#2 ADO SPT
Peak (+)dP/dt (mm Hg/sec)
Precardioplegia 2380 ± 68 2468 ± 82 2289 ± 76
30-min reperfusion 1789 ± 120* 2256 ± 78 1845 ± 142
60-min reperfusion 1640 ± 135*† 1981 ± 116* 1482 ± 77*†
Coronary flow (mL/min)
Precardioplegia 16.0 ± 2.0 15.5 ± 1.8 15.8 ± 0.9
30-min reperfusion 13.0 ± 2.0 11.8 ± 0.8 13.5 ± 2.3
60-min reperfusion 12.8 ± 1.8 10.2 ± 0.7 11.8 ± 2.0
In the three groups that underwent cardioplegic arrest, there were significant decreases in peak (+)dP/dt during reperfusion compared with precardioplegic arrest val-
ues. In the ST#2 (n = 7) and SPT (n = 7) groups, at 60 minutes of reperfusion the peak (+)dP/dt was significantly less than at 60 minutes of reperfusion in the ADO
group (n = 6). Coronary flow measured before cardioplegic arrest showed no significant differences among the three cardioplegia groups (n = 6 each). After 30 and
60 minutes of reperfusion, there were no significant differences in any of the groups compared with precardioplegia values and there were no significant intergroup
differences in coronary flow.
*P < .05 compared with precardioplegia.
†P < .05 compared with ADO at 60 minutes of reperfusion.
Table II. Changes in compliance coefficients
Group Time (min) ∆V
o
∆lnA ∆lnB
ST#2 30-min reperfusion 15.30 ± 2.60* 0.854 ± 0.165* –0.226 ± 0.048
60-min reperfusion 17.26 ± 2.11* 0.574 ± 0.300* –0.102 ± 0.164
ADO 30-min reperfusion 11.21 ± 8.76* –0.277 ± 0.124 0.194 ± 0.137
60-min reperfusion 9.44 ± 6.17* 0.044 ± 0.502 0.143 ± 0.301
SPT 30-min reperfusion 14.76 ± 4.77* 0.654 ± 0.586* 0.470 ± 0.315*
60-min reperfusion 8.65 ± 6.29* 0.181 ± 0.450 0.726 ± 0.238*
Effects of cardioplegic arrest and reperfusion in the three cardioplegia groups on the equilibrium volume (V
o
) and compliance coefficients. The equilibrium volume
increased significantly after cardioplegic arrest at 30 and 60 minutes of reperfusion in all three groups that had undergone cardioplegic arrest. Compliance coeffi-
cients A and B are presented in their natural logarithmic converted form for comparison. In the ST#2 group there was a significant increase in the A coefficient, but
B was unchanged from precardioplegia values. In the adenosine-supplemented group there was no significant change in either A or B. In the SPT group, A was sig-
nificantly increased at 30 minutes of reperfusion, but returned to a value no different from baseline by 60 minutes. However, the B coefficient in the SPT group was
significantly increased at both times. For all groups, n = 6.
*P < .05 compared with zero.
in the ADO group than in the ST#2 group. For the three
cardioplegia groups there were no significant changes
in coronary flow after cardioplegic arrest and reperfu-
sion as compared with baseline values, nor were there
any significant differences between the groups (P = .2).
When the left ventricular EDPVR was normalized
for the equilibrium volume by the equation Y = A ·
(expB · Vn–1), changes in compliance were assessed. Fig
2 is a representative example of compliance curves
from one heart in the ST#2 group. Before cardioplegic
arrest the values of the A and B coefficients were
22.817 and 1.869, respectively. However, after 60 min-
utes of reperfusion, coefficient A increased to 27.914
and B increased to 2.237. These changes in the A and
B coefficients translated to a decrease in compliance, or
a shift in the compliance curves up and to the left. The
equilibrium volume after reperfusion increased signifi-
cantly from baseline in all three cardioplegia groups,
indicating a shift in the left ventricular EDPVR to the
right (Table II). Because the stress/strain relationship is
monoexponential, natural logarithmic conversion of the
coefficients was required for statistical comparison.
Changes in the A and B coefficients are shown in Table
II as their natural logarithmic converted form. In the
ST#2 group, the B coefficient was unchanged (P = .6),
but A was significantly increased during reperfusion
compared with values before cardioplegic arrest. Thus
there was a significant decrease in compliance in these
hearts. In the ADO group, there was no significant
change in either coefficient (P = .7), indicating that
compliance was unchanged in the ADO group after
cardioplegic arrest and reperfusion. In the SPT group
there was a significant increase in the A coefficient at
30 minutes of reperfusion and in the B coefficient dur-
ing reperfusion at both times, indicating that the pre-
vention of decreased compliance by adenosine supple-
mentation was adenosine-receptor mediated.
Myofibrillar ATPase activity. The myofibrillar pCa-
ATPase activity relation was assessed to determine
whether the decrease in myofilament ATPase coopera-
tivity previously demonstrated in our laboratory14 after
cardioplegic arrest and reperfusion might be altered by
the supplementation of adenosine in the cardioplegic
solution. The pCa50 was used as a measure of myofi-
brillar Ca2+ sensitivity and the Hill coefficient was a
measure of cooperative activation of the myofilaments.
Data for myofibrillar ATPase activity are shown in
Table III. Similar to results in our previous work,14 the
Hill coefficient was significantly depressed in the ST#2
group, relative to that in hearts that did not undergo car-
dioplegic arrest. No significant changes were observed
in the other variables, in agreement with our previous
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Table III. Myofibrillar ATPase measurements
Group pCa50 Hill Minimum Maximum
ST#2 (n = 7) 6.15 ± 0.03 2.12 ± 0.08* 37.91 ± 10.2 148.30 ± 17.7
ADO (n = 6) 6.12 ± 0.04 2.50 ± 0.13 35.97 ± 6.7 152.18 ± 16.5
SPT (n = 8 6.10 ± 0.03 2.16 ± 0.04* 26.90 ± 3.1 152.67 ± 10.1
No CPL (n = 6) 6.03 ± 0.06 2.48 ± 0.04 29.10 ± 3.7 143.97 ± 8.3
There were no differences between the groups with respect to calcium sensitivity (pCa50) minimum, or maximum enzyme activity. Relative to the No CPL group,
cooperative interaction (Hill coefficient) was significantly depressed in the ST#2 and SPT groups, but not in the ADO group.
*Difference from No CPL value.
Table IV. Effluent lactate concentrations (in micromoles per liter)
Cardioplegic arrest Reperfusion
Group Precardioplegia 30 min 60 min 90 min 30 min 60 min
ST#2 40 ± 20 240 ± 150*† 370 ± 50* 100 ± 70† 70 ± 20 60 ± 30
ADO 50 ± 20 480 ± 200* 460 ± 210* 570 ± 260* 70 ± 20 100 ± 40
SPT 50 ± 40 110 ± 60†‡ 120 ± 70†‡ 110 ± 50† 40 ± 20 90 ± 70
Effluent lactate concentrations were significantly elevated in the ST#2 group (n = 7) at 30 and 60 minutes of reperfusion compared with baseline but returned to pre-
cardioplegia values by 90 minutes of reperfusion. In the ADO group (n = 6) there was a significant increase in effluent lactate at all cardioplegic arrest time points
and this was significantly greater than that in the ST#2 group at 30 and 90 minutes of cardioplegic arrest. When adenosine receptors were blocked (SPT group; n =
7) there was no significant increase in effluent lactate during cardioplegic arrest, and values were significantly lower than in the ADO group at all times and signifi-
cantly lower than values in ST#2 hearts at 60 minutes.
*Significant difference from baseline (P < .05).
†Significant difference from ADO (P < .05).
‡Significant difference from ST#2 (P < .05).
work.14 In the ADO group, the Hill coefficient was not
significantly depressed, demonstrating that adenosine
supplementation of cardioplegic solution can prevent
the changes in myofilament interactions associated
with cardioplegic arrest. In the presence of 8-p-sul-
fophenyltheophylline (SPT group), the ability of
adenosine to prevent the depression in myofilament
cooperativity was absent, indicating that this was an
adenosine-receptor-mediated phenomenon. Therefore
it appears likely that one of the mechanisms of adeno-
sine-mediated improvement in myocardial protection is
secondary to effects on the myofilament interactions.
Glycolytic activity. Effluent lactate concentrations
are shown in Table IV. Effluent lactate levels were sig-
nificantly increased (10-fold) in the ST#2 group hearts
at 30 and 60 minutes of cardioplegic arrest, but
returned to precardioplegia levels by 90 minutes.
Hearts in the ADO group displayed a significant
increase in effluent lactate levels at 30, 60, and 90 min-
utes of cardioplegic arrest, compared with baseline lev-
els, and significantly higher levels at 30 and 90 minutes
than levels in ST#2 hearts. This suggests that supple-
mentation of cardioplegic solution with adenosine
increases anaerobic glycolysis during the duration of
cardioplegic arrest. When adenosine receptors were
blocked with 8-p-sulfophenyltheophylline, neither the
increase in effluent lactate seen in the ADO group nor
that in the ST#2 group during cardioplegic arrest was
evident, confirming that this was an adenosine-recep-
tor–mediated response. At 60 minutes of cardioplegic
arrest, both the ADO and the ST#2 groups had effluent
lactate levels that were higher than that in the SPT
group, but the ADO group and the ST#2 group effluent
levels were not significantly different. This intermedi-
ate response in the ST#2 group implicates an important
role of endogenous adenosine in myocardial protection
during cardioplegic arrest.
Discussion
The results of this study demonstrate that adenosine
supplementation of cardioplegic solution improves
myocardial functional recovery, which concurs with
results obtained by other investigators.3-5,17,18 In
regard to the cellular mechanism of the improved
recovery attributable to adenosine supplementation of
cardioplegic solution, our data support two primary
conclusions. Adenosine, via a receptor-mediated
action, prevented the depression in myofibrillar coop-
erative action seen after cardioplegic arrest and reper-
fusion. This is evidenced by prevention of a decrease
in the Hill coefficient in the ADO group and the rever-
sion to decreased cooperativity in the presence of an
adenosine-receptor antagonist. Improvements in post-
cardioplegic function were also associated with adeno-
sine-receptor–mediated increased anaerobic glycolysis
during cardioplegic arrest. This is indicated by the
increase in effluent lactate concentrations collected in
the ADO group, an effect ablated with adenosine-
receptor blockade.
Our finding that the addition of adenosine during car-
dioplegic arrest improves recovery of myocardial
mechanical function concurs with observations by
other investigators.3-5,17,18 We observed improvements
in systolic pressure generated in the ADO group rela-
tive to results in the other two cardioplegic groups. In
fact, both the ST#2 and the SPT groups had a signifi-
cant decrease in systolic pressure generation, whereas
the adenosine-supplemented group had no significant
decrease. Hudspeth and coworkers3 demonstrated that
supplementation of blood cardioplegic solution with
adenosine led to improvements in systolic recovery.
More specifically, they observed an attenuation in the
decrease in the slope of the end-systolic pressure-vol-
ume relationship after cardioplegic arrest and reperfu-
sion in the adenosine-supplemented group, which was
not evident in their control group. The improvements in
diastolic recovery seen in the adenosine-supplemented
group also correlate with findings by other investiga-
tors.3,5,18 Bolling and associates18 demonstrated
improved myocardial functional recovery after cardio-
plegic arrest and reperfusion with the supplementation
of cardioplegic solution with either adenosine or 2-
deoxycoformycin, a noncompetitive inhibitor of adeno-
sine deaminase, the enzyme responsible for the degra-
dation of adenosine to inosine.
Much of the prior work examining changes in com-
pliance in adenosine-supplemented cardioplegic solu-
tion did not account for changes in the equilibrium vol-
ume of the left ventricle. It is necessary to evaluate
changes in equilibrium volume to assess the
stress/strain relationship. Once ventricular volume is
normalized for the equilibrium volume, the stress/strain
relationship (compliance) can be characterized by a
monoexponential function, which was first described
by Glanz and Parmley.16 In the present study, there was
a significant decrease (shift of the curve up and to the
left) in compliance in the ST#2 group, as indicated by
an increase in coefficient A. However, in the adenosine-
treated group these changes were not evident. In con-
trast, when the adenosine receptors were blocked with
8-p-sulfophenyltheophylline, the improvements in
recovery of compliance attributable to adenosine were
attenuated. Although these changes in diastolic func-
tion would contribute to improved ventricular filling
The Journal of Thoracic and
Cardiovascular Surgery
Volume 119, Number 3
Fogelson, Nawas, Law 607
during diastole, they might also lead to improvements
in systolic function.
Prior work from our laboratory demonstrated specif-
ic alterations in biochemical interactions in the myofi-
brillar contractile apparatus as a result of cardioplegic
arrest.14 In this study, the cooperative interaction (Hill
coefficient) of the actin-myosin Mg+2 ATPase was
decreased after cardioplegic arrest. This finding was
consistent in groups that underwent 2 hours of cardio-
plegic arrest with St Thomas’ Hospital No. 2 cardio-
plegic solution with or without reperfusion, indicating
that the decreased myofilament cooperativity was a
result of the cardioplegic arrest and not secondary to
reperfusion injury. These alterations would contribute
to both the systolic and diastolic dysfunction seen after
cardioplegic arrest and reperfusion. Our current finding
of an adenosine-receptor–mediated prevention of both
the decreased cooperativity and the decreased systolic
and diastolic function associated with cardioplegic
arrest lends further credence to this hypothesis. The
specific alterations in myofilaments responsible for
these changes are still unknown. We have previously
shown no evidence of protein degradation after cardio-
plegic arrest,14 as has been shown to occur in warm
ischemia.19 The relative steepness of the activation of
myofilament activity by Ca++ is a complex function of
protein-protein interactions within a functional unit
between near-neighbor functional units. As such, the
alterations that would be responsible for the changes
we have found in cooperative activation are likely to be
subtle. It is clear from previous work that minor
changes in protein interactions among thin filament
proteins may be amplified considerably in terms of
functional changes.20
Adenosine has been shown to increase myocardial
glucose uptake11-13 and glycolysis,8,21 and this response
has been shown to be associated with functional pro-
tection during warm ischemia,7 ischemic precondition-
ing,22 and critical coronary stenosis.10 However, work
by Ning and colleagues15 suggested that myocardial
glycolysis might reach a temperature threshold during
cardioplegic arrest. Increased glycolysis was associated
with cardioprotection during cardioplegic arrest only
when temperatures were equal to or greater than 30°C;
temperatures lower than this were not associated with
increased glycolysis. However, we found that adeno-
sine-supplemented cardioplegic solution was associat-
ed with receptor-mediated increased anaerobic glycol-
ysis throughout cardioplegic arrest, as evidenced by
increased effluent lactate levels. These findings corrob-
orate those recently reported by Friehs and cowork-
ers,23 who also demonstrated significant increases in
total lactate production when hearts were arrested with
adenosine-supplemented cardioplegic solution. In the
present study, there was a response in the ST#2 group
intermediate to those in the ADO and SPT groups;
effluent lactate levels were significantly increased at 30
and 60 minutes of cardioplegic arrest but returned to a
value not different from baseline by 90 minutes. This
intermediate response is most likely a result of endoge-
nous adenosine production, because both this and the
amplified response seen in the ADO group were lost in
the presence of 8-p-sulfophenyltheophylline. Thus, as
in normothermic settings, it appears that adenosine is
capable of increasing anaerobic glycolysis in the set-
ting of cold cardioplegic arrest. Because these changes
in anaerobic glycolysis paralleled the changes seen in
functional recovery among the three cardioplegia
groups, it is likely that increased anaerobic glycolysis
contributes to the improved myocardial protection
attributed to the supplementation of cardioplegic solu-
tion with adenosine.
A number of cellular events probably contribute to
the salutary effects of adenosine-supplemented cardio-
plegic solution, but only recently have studies begun to
identify these mechanisms. The present study is the
first to implicate improvements in myofilament inter-
actions as a mechanism of the action of adenosine in
this unique setting of hypothermic arrest, and the study
confirms the importance of increased glycolytic activi-
ty in this setting as well. Further study to determine the
specific cellular changes responsible for these effects
may lead to methods of optimizing these mechanisms
for use in cardiac operations.
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